Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zydus announces Phase I trials of ZYIL1, oral small molecule NLRP3 inflammasome inhibitor
NLRP3 inflammasomes lead to the onset and development of diseases like ARDS, auto-immune diseases, inflammatory diseases, CVDs,…
Agilent confers Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore
Prof Rathore, the first researcher in India to receive this award; has been recognised for his contributions to biopharma research
Sinovac get $515 mn funding for COVID-19 vaccine production
Sinovac said that it would be able to manufacture 300 million vaccine doses annually and aims to complete construction of a second…
Bayer, Atara Biotherapeutics to partner for mesothelin-targeted CAR T-cell therapies
The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous version,…
Serum Institute applies for EUA for Covishield in India
According to sources, this vaccine is logistically feasible for distribution in the country's both urban and rural parts as it can…
Career prospects in pharma in the new normal
The pharma sector is moving from being traditional to a highly technology-driven one, highlights Sanjeev Goel, Business Head,…
Pfizer seeks EUA for COVID-19 vaccine in India
It is the first company to seek approval for its vaccine in India
AIOCD writes to PM about possible shortage of essential medicines due to farmers agitation
Requests government to ensure supply of medicines by providing secure passage to medicine transporters
Regenerative medicine market to reach $16.4 bn in 2026: GlobalData
There are currently 53 marketed RM products and 175 RM pipeline agents in development in the eight major markets
COVID-19 vaccine will not be made mandatory: Joe Biden
Biden said he is willing to get inoculated in public to assuage any concerns about the vaccines’ efficacy and safety